ANGELA LOVE

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease SYRACUSE, NY NPI 1255697140

General Payments — all program years on this page

$537.73

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 28
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $252.27 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $236.0311
Education $16.241

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $65.572
ABIOMED $41.202
Acerta Pharma LLC $28.542
Axsome Therapeutics, Inc. $23.891
GlaxoSmithKline, LLC. $20.791
INOGEN, INC. $20.331
ABBVIE INC. $19.271
Regeneron Healthcare Solutions, Inc. $16.441
Insmed, Inc. $16.241

By program year

Program yearAmountRecords
2021 $75.594
2022 $26.502
2023 $183.3710
2024 $252.2712

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089555664 Insmed, Inc. $16.24 08/09/2024 Education Undisputed 01/23/2026 View at CMS
1104904178 ABBVIE INC. $19.27 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105541665 AstraZeneca Pharmaceuticals LP $14.19 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105668989 AstraZeneca Pharmaceuticals LP $14.35 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111637952 Amgen Inc. $32.54 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111637954 Amgen Inc. $33.03 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114103659 Regeneron Healthcare Solutions, Inc. $16.44 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116334175 GlaxoSmithKline, LLC. $20.79 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142202647 ABIOMED $19.70 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142202649 ABIOMED $21.50 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144988591 INOGEN, INC. $20.33 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148264543 Axsome Therapeutics, Inc. $23.89 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.